Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-25-000118

Chief Medical Officer sold 2,454 shares at $43.78 ($107,436)

  • Chief Medical Officer acquired 2,454 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-11-11 Exercise or conversion : show line 1 in the form 10b5-1 +2,454 $25.01 $61,375 64,181 D
2025-11-11 Sale : show line 2 in the form 10b5-1 −2,454 $43.78 $107,436 61,727 D
Open-market sales · 2,454 sh · avg $43.78 · $107,436

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-11-11 Exercise or conversion : show line 3 in the form 10b5-1 Stock options (right to buy) −2,454 26,130 D
Loading xslF345X05/wk-form4_1763068136.xml…